CSMed
ActiveSummary
CSMed has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €38,679 and a net result of €1,133. Its solvency ranks better than 30% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
13-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 13 days late
2025
28-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 28 days late
2024
29-02
Gazette deed
IncorporationAppointment: STROUVEN Carlo (director) · Founder · Registered office clause8 facts ▸
Gazette deed
Incorporation
Appointment: STROUVEN Carlo (director) · Founder · Registered office clause8 facts ▸
- Incorporation, “CSMed” (deed in Dutch)
- Founder, STROUVEN Carlo
- Registered office clause, “Vlaamse Gewest, 2000 Antwerpen,Italiëlei 10 bus 102” (deed in Dutch)
- Founding capital, €2,000
- Bank account, “bijzondere rekening ten name van vennootschap in oprichting”, 19-02-2024 (deed in Dutch)
- Capital contribution, €2,000
- Pre-incorporation commitments, ratification, “alle verrichtingen sedert 01-01-2023 namens haar aangegaan door oprichter” (deed in Dutch)
- Director appointment, STROUVEN Carlo (director)
Gazette deedNBB filing
1 of 1 deed read